MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Was the deep brain stimulation surgery successful? Is it the same for the physician and the patient ?

    M. Contreras Pinto, J. Hortal, S. Torres, M. Ramirez (la serena, Chile)

    Objective: To compare the physician`s assessment and the patient perception of the definition of successful therapy in STN DBS. Background: Although the treatment of Parkinson's…
  • 2023 International Congress

    LRRK2 Inhibition by BIIB122/DNL151 Demonstrates Robust Target and Lysosomal Engagement: Pharmacokinetics, Pharmacodynamics and Safety in Phase 1 and Phase 1b Studies in Healthy and Parkinson’s Participants

    S. Dhuria, P. Roychowdhury, H. Wong, S. Huntwork-Rodriguez, H. Solanoy, M. Goo, R. Maciuca, O. Mabrouk, K. Fraser, K. Scearce-Levie, D. Graham, D. Jennings, M. Troyer (South San Francisco, USA)

    Objective: To characterize the pharmacokinetics (PK), pharmacodynamics, safety, and exposure-response (E-R) relationships of BIIB122/DNL151 to inform on clinical dose selection. Background: Increased LRRK2 kinase activity…
  • 2023 International Congress

    Nucleus basalis of Meynert and total gray matter atrophy are related to cognitive and gait decline in Parkinson’s disease

    A. Yeung, F. Ba, M. Gee, R. Camicioli (Edmonton, Canada)

    Objective: To assess the associations between the nucleus basalis of Meynert (NBM) and total grey matter atrophy with cognitive phenotype and gait measures in a…
  • 2023 International Congress

    PET visualization of α-synuclein pathologies in humans using [18F]C05-05

    H. Endo, K. Matsuoka, Y. Kataoka, K. Tagai, K. Hirata, N. Kokubo, A. Orihara, M. Oya, H. Matsumoto, S. Kurose, M. Ichihashi, A. Oyama, S. Kitamura, H. Zhang, C. Seki, K. Takahata, T. Tokuda, M. Ono, Y. Takado, H. Shinotoh, A. Sugiyama, T. Hatano, H. Shimada, K. Kawamura, MR. Zhang, M. Higuchi (Chiba, Japan)

    Objective: This study aimed to visualize α-synuclein aggregates in living patients with Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA).…
  • 2023 International Congress

    Differences in gray matter atrophy and functional connectivity between motor subtypes of Parkinson’s disease

    L. Yin, J. Fu, Z. Xu (kunming, China)

    Objective: This study compared gray matter volume (GMV) and functional connectivity among patients with Parkinson’s disease involving postural instability/gait difficulty (PD-PIGD), patients with tremor-dominant Parkinson’s disease (PD-TD) and healthy…
  • 2023 International Congress

    Clinical and functional determinants of motor reserve in patients with de novo Parkinson’s disease

    S. Prange, M. Hoenig, H. Theis, E. Metereau, S. Thobois, T. van Eimeren (Cologne, Germany)

    Objective: To determine the clinical determinants and the role of serotonergic innervation on motor reserve in patients with de novo Parkinson's disease. Background: Patients with…
  • 2023 International Congress

    Bilateral staged MR-guided focused ultrasound thalamotomy for Essential Tremor: one-year follow-up results

    S. Mahendran, F. Büchele, M. Uhl, C. Freudinger, M. Oertel, C. Baumann, L. Stieglitz (Zurich, Switzerland)

    Objective: To evaluate the safety and efficacy outcomes of bilateral staged magnetic resonance guided focused ultrasound (MRgFUS) thalamotomy for medication-refractory essential tremor (ET) and ET…
  • 2023 International Congress

    Effectiveness of speech therapy in patients with Parkinson’s disease – a randomized controlled trial

    J. Maas, N. de Vries, B. Bloem, H. Kalf (Nijmegen, Netherlands)

    Objective: We aimed to assess the effectiveness of speech therapy on improving quality of life and speech quality in patients with Parkinson’s disease. Background: Although…
  • 2023 International Congress

    London-Dhaka Parkinson’s Cognition Study: A collaboration to evaluate cognitive impairment in under-represented Parkinson’s disease patients

    T. Zannat, K. Dey, A. Zirra, A. Haque, E. Camboe, T. Haque, S. Waters, D. Mair, C. Marshall, A. Noyce, A. Habib (Dhaka, Bangladesh)

    Objective: Our aim is to study the prevalence of cognitive impairment (CI) in a diverse group of people with Parkinson's disease (PwP) from East London,…
  • 2023 International Congress

    Development and validation of a new wearable device for the differential diagnosis of resting tremor

    M. de Maria, F. Aracri, C. Calomino, M. Crasà, J. Buonocore, B. Vescio, A. Quattrone (Catanzaro, Italy)

    Objective: To develop a new easy-to-use wearable device to estimate the muscular contraction pattern of rest tremor (RT) using inertial data. Background: The RT pattern…
  • « Previous Page
  • 1
  • …
  • 155
  • 156
  • 157
  • 158
  • 159
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #23862 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley